44.62
price up icon2.32%   1.01
after-market Handel nachbörslich: 44.82 0.20 +0.45%
loading
Schlusskurs vom Vortag:
$43.61
Offen:
$45
24-Stunden-Volumen:
2.98M
Relative Volume:
3.09
Marktkapitalisierung:
$8.22B
Einnahmen:
$455.99M
Nettoeinkommen (Verlust:
$-285.01M
KGV:
-13.69
EPS:
-3.26
Netto-Cashflow:
$-164.61M
1W Leistung:
-1.85%
1M Leistung:
-9.07%
6M Leistung:
-1.74%
1J Leistung:
-32.36%
1-Tages-Spanne:
Value
$44.47
$47.79
1-Wochen-Bereich:
Value
$42.84
$47.79
52-Wochen-Spanne:
Value
$38.60
$70.13

Legend Biotech Corp Adr Stock (LEGN) Company Profile

Name
Firmenname
Legend Biotech Corp Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1,800
Name
Twitter
@LegendBiotech
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
LEGN's Discussions on Twitter

Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-19 Eingeleitet Scotiabank Sector Perform
2023-11-06 Eingeleitet Goldman Buy
2023-05-25 Eingeleitet William Blair Mkt Perform
2023-05-22 Eingeleitet Daiwa Securities Buy
2023-03-29 Eingeleitet H.C. Wainwright Buy
2023-03-24 Eingeleitet RBC Capital Mkts Outperform
2022-12-06 Eingeleitet UBS Buy
2022-11-02 Eingeleitet Evercore ISI Outperform
2022-11-01 Eingeleitet Cowen Outperform
2022-10-31 Eingeleitet Guggenheim Neutral
2022-06-17 Eingeleitet BMO Capital Markets Outperform
2022-03-15 Eingeleitet Barclays Overweight
2022-01-31 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-01-06 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-12-21 Eingeleitet Piper Sandler Overweight
2021-05-18 Eingeleitet BTIG Research Buy
2020-07-01 Eingeleitet JP Morgan Overweight
2020-07-01 Eingeleitet Jefferies Buy
2020-06-30 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Legend Biotech Corp Adr Aktie (LEGN) Neueste Nachrichten

pulisher
02:42 AM

Legend Biotech's SWOT analysis: carvykti success drives stock outlook - Investing.com

02:42 AM
pulisher
Nov 04, 2024

Gilead Science to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research

Nov 04, 2024
pulisher
Nov 04, 2024

Legend Biotech appoints new President for CARVYKTI - Investing.com

Nov 04, 2024
pulisher
Oct 28, 2024

Legend Biotech Corp ADR (NASDAQ:LEGN) Stock Is up 15.91% From Its Low, This Stock Is Just Warming Up - Stocks Register

Oct 28, 2024
pulisher
Oct 24, 2024

Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade - Yahoo Finance

Oct 24, 2024
pulisher
Oct 17, 2024

Adma Biologics Inc (ADMA) Should Be Considered For The Next Few Weeks - Stocks Register

Oct 17, 2024
pulisher
Oct 17, 2024

Legend Biotech shares hold Buy rating, $91 target despite Q3 CARVYKTI sales - Investing.com India

Oct 17, 2024
pulisher
Oct 17, 2024

Legend Biotech shares hold as Barclays maintains $94 target - Investing.com India

Oct 17, 2024
pulisher
Oct 16, 2024

Company’s Banking Stock: Dissecting a -18.35% Quarterly Revenue Decline Amid Growth - The InvestChronicle

Oct 16, 2024
pulisher
Oct 16, 2024

Redburn Atlantic initates Legend Biotech Corp ADR (LEGN) rating to a Buy - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Li Auto Inc ADR (LI) rating downgrades by Macquarie - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Recent Insider Activity Suggests Potential Gains for Enovix Corporation (ENVX) - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Legend Biotech on strong sales - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Legend Biotech on strong sales By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 15, 2024

Stock Performance Spotlight: Legend Biotech Corp ADR (LEGN) Ends the Day at 49.68, Down by -0.64 - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Legend Biotech Corp ADR’s results are impressive - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

UnitedHealth, NVIDIA lead Tuesday's afternoon market cap stock movers - Investing.com

Oct 15, 2024
pulisher
Oct 11, 2024

Legend Biotech maintains shares price target on steady Q3 growth - Investing.com

Oct 11, 2024
pulisher
Oct 11, 2024

Legend Biotech Corp ADR’s Mixed Bag: Down -8.63% in 6 Months, Down 1.03% in 30 Days - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Market Insights: Legend Biotech Corp ADR (LEGN)’s Notable Gain of 1.62, Closing at 48.84 - The Dwinnex

Oct 10, 2024
pulisher
Oct 09, 2024

Legend Biotech shares hold strong with positive outlook on robust Carvykti sales - Investing.com

Oct 09, 2024
pulisher
Oct 08, 2024

Legend Biotech Corp ADR (LEGN) is a good investment, but the stock may be overvalued - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Redburn sees growth potential for Legend Biotech stock on Carvykti demand - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

Does Legend Biotech Corp ADR (LEGN) offer a good opportunity for investors? - SETE News

Oct 07, 2024
pulisher
Oct 04, 2024

Legend Biotech stock maintains positive outlook with new Philadelphia R&D facility - Investing.com

Oct 04, 2024
pulisher
Oct 03, 2024

Upward Trajectory: Legend Biotech Corp ADR (LEGN) Posts a Gaine, Closing at 48.68 - The Dwinnex

Oct 03, 2024
pulisher
Oct 02, 2024

Legend Biotech Corp ADR (LEGN) stock analysis: A simple moving average approach - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

You might want to take a look at Legend Biotech Corp ADR (LEGN) now - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Legend Biotech shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

BMO maintains Outperform rating on Legend Biotech shares on Carvykti data - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech shares maintain Buy rating from H.C. Wainwright - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech's SWOT analysis: carvykti success drives stock potential - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech reiterates stock target, overweight on Phase III data - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Legend Biotech stock poised for growth with compelling data on Carvykti - Investing.com

Sep 30, 2024
pulisher
Sep 26, 2024

Legend Biotech Corp ADR (LEGN) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Sep 26, 2024
pulisher
Sep 25, 2024

Can you now get a good deal on Legend Biotech Corp ADR’s shares? - US Post News

Sep 25, 2024
pulisher
Sep 24, 2024

There is no doubt that Legend Biotech Corp ADR (LEGN) ticks all the boxes. - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Closing Bell Recap: Legend Biotech Corp ADR (LEGN) Ends at 45.92, Reflecting a -5.38 Downturn - The Dwinnex

Sep 24, 2024
pulisher
Sep 20, 2024

Analytical Lens: Exploring Legend Biotech Corp ADR (LEGN)’s Financial Story Through Ratios - The Dwinnex

Sep 20, 2024
pulisher
Sep 19, 2024

What was Legend Biotech Corp ADR (LEGN)’s performance in the last session? - US Post News

Sep 19, 2024
pulisher
Sep 18, 2024

European Investors Can Invest in the Future of U.S. Healthcare With This ETF - Trackinsight

Sep 18, 2024
pulisher
Sep 17, 2024

Legend Biotech Corp ADR (LEGN) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 17, 2024
pulisher
Sep 13, 2024

Financial Analysis: Legend Biotech Corp ADR (LEGN)’s Ratios Unveil Key Insights - The Dwinnex

Sep 13, 2024
pulisher
Sep 10, 2024

This trade activity should not be overlooked: Legend Biotech Corp ADR (LEGN) - SETE News

Sep 10, 2024
pulisher
Sep 06, 2024

Legend Biotech Corp ADR (LEGN)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Sep 06, 2024
pulisher
Sep 06, 2024

Legend Biotech Corp ADR (LEGN) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Sep 06, 2024
pulisher
Sep 05, 2024

Is Central Puerto (CEPU) Stock Outpacing Its Oils-Energy Peers This Year? - Yahoo Finance

Sep 05, 2024
pulisher
Sep 04, 2024

Earnings Estimates Rising for Atour Lifestyle Holdings Limited Sponsored ADR (ATAT): Will It Gain? - Yahoo Finance

Sep 04, 2024
pulisher
Sep 04, 2024

Wall Street Analysts Believe Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Could Rally 47.49%: Here's is How to Trade - Yahoo Finance

Sep 04, 2024
pulisher
Sep 03, 2024

Hello Group Inc. Sponsored ADR (MOMO) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Sep 03, 2024
pulisher
Aug 31, 2024

Chevron Corp (CVX): A Good 52-Week Low Stock to Buy Now According to Short Sellers - Yahoo Finance

Aug 31, 2024

Finanzdaten der Legend Biotech Corp Adr-Aktie (LEGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):